Some brain tumors mimic the genetic program of germline cells

December 23, 2010

Scientists at IRB Barcelona have discovered that some brain tumours in larvae of the fruit fly Drosophila melanogaster use the genetic programme of germline cells to grow. The removal of some of these genes leads to healthy brains. This finding demonstrates that these genes are crucial for tumour development. The study, headed by ICREA researcher Cayetano González, is published today in the prestigious journal Science.

One of the characteristics of tumour cells is their immortality, a property that allows them to divide without obeying external signals. As a result, tissue masses form, which, in most cases, interfere with organ functions. Data collected in recent years reveal than many human tumours activate specific genes of the germinal cell line - those specialized in spermatozoids or ovules -, which is thought to allow them greater and longer viability. However, the role of these genes in tumour development remains to be established. In this study, the scientists showed for the first time that silencing some of these genes leads to the disappearance of tumours in the brain of the fruit fly.

Global analysis of gene expression in tumours

Not all cells use the same genes, but they make use of them depending on the function to be performed. This gene activation profile is what determines how cells divide and what they become specialized in, in the case they have not already done so. In this study the researchers have used DNA chip technology to monitor this gene activity in tumour cells and have compared it with healthy cells. For this purpose, they have analysed brain tumours induced by an alteration in the gene l[3]mbt in fruit fly larvae.

Analysis of the gene expression profiles indicates that these tumour cells activate a total of 102 genes that are not activated in healthy cells. When the researchers examined the functions of these genes they observed that, in many cases, they were unknown, although 25% of them were responsible for functions related to germline cells. "These results show that these tumours mimic the gene expression profiles of germline cells", explains Ana Janic, first author of the study and PhD student in González's lab.

Germline genes contribute to tumour growth

When the scientists studied the possible role of these specific genes of the germinal cell line in tumour expansion, they observed that by the silencing four lead to the development of healthy brains. "These experiments demonstrate that these genes are crucial for the development of this kind of tumour", states Janic.

Data collected over the last ten years indicate that the cancer cells of some tumours, such as melanomas and some kinds of carcinoma, activate genes of the germinal cell line. One possible diagnostic approach derived from these studies would be to use some of the proteins produced by these genes as tumour cell markers. In this context, the use of these proteins to make cancer vaccines is of particular relevance. This study sheds new light on the role of these proteins in the pathogenesis of cancer and opens up the way for new lines of research for the development of treatment against this disease in humans.
-end-
Reference article: Ectopic expression of germline genes drives malignant brain tumor growth in Drosophila. Janic A, Mendizabal L, Llamazares S, Rossell D, Gonzalez C. Science (2010) [doi: 10.1126/science.1195481]

Institute for Research in Biomedicine (IRB Barcelona)

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.